Effect of apatinib mesylate combined with TACE in treatment of advanced hepatocellular carcinoma and its influence on serum levels of VEGF and MMP-9
Qing Yang(Guangzhou University of Chinese Medicine), Xiaoju Zhuge(Wenzhou Medical University), Songsong Pan(Wenzhou Medical University), Xiangpang Xie(Wenzhou Medical University), Bingru Zheng(Wenzhou Medical University), Changsheng Shi(Wenzhou Medical University)
Cited by 3
Related Papers
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
|British Journal of Cancer|2018|156
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
|Science Translational Medicine|2019|138